Skip to content

Bioequivalence Study for Benzyl Alcohol Lotion 5%.

Bioequivalence Study for Benzyl Alcohol Lotion 5% (Hi-Tech Pharmacal Co. LTD) and Ulesfia (Benzyl Alcohol Lotion 5%) (Shionogi Inc.) in the Treatment of Head Lice and Their Ova.

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02624843
Enrollment
239
Registered
2015-12-09
Start date
2015-08-31
Completion date
2015-11-30
Last updated
2021-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Head Lice

Brief summary

To establish the therapeutic equivalence and safety of a generic Benzyl Alcohol Lotion 5% with Ulesfia Lotion 5% in eradication of head lice in the study subjects.

Interventions

DRUGBenzyl Alcohol Lotion 5%

White topical lotion

DRUGUlesfia (benzyl alcohol lotion) 5%

White topical lotion

DRUGPlacebo

White topical lotion

Sponsors

South Florida Family Health and Research Centers
CollaboratorNETWORK
Axis Clinical Trials
CollaboratorOTHER
Akorn, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
6 Months to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy males or non-pregnant females aged 6 month or over with an upper age limit of 60 years. * Prospective participants upon examination are confirmed to have at least 3 live head lice (defined as lice adults or nymphs) and at least 5 viable appearance louse eggs (nits). * Prospective participants who give written informed consent or, if the participant is under 17 years of age, whose parent/guardian gives written informed consent to participate in the study. * Prospective participants who will be available for follow up visits over the 21 days following first treatment. * Prospective female participants (including female caregivers) of childbearing potential who are willing to provide a urine pregnancy test. * Prospective participants who agree not to shave their hair or use any other pediculicide, nit combing, or louse treatment method during the course of the study.

Exclusion criteria

* Prospective participants with a known sensitivity to any of the ingredients in benzyl alcohol lotion 5% (Hi-Tech Pharmacal Inc) or Ulesfia 5% (Shionogi Inc). * Prospective participants with a known history of irritation or sensitivity to pediculicides or hair care products. * Prospective participants with a secondary bacterial infection of the scalp (eg. impetigo/pyoderma) or have a secondary or long term scalp condition that could make it difficult to evaluate the extent and severity of an infestation or that would present a problem in the evaluation of response to therapy (e.g., psoriatic lesions of the scalp, extensive seborrheic dermatitis). * Prospective participants who have been treated with other head lice products within 4 weeks prior to randomization. * Prospective participants who regularly shave their hair, have bleached their hair, used a permanent color on their hair, or their hair has been permanently straightened or waved within the previous 2 weeks. * Prospective participants who have been treated with Trimethoprim containing products within the previous 4 weeks, or who are currently taking such a course. * Females who are pregnant, planning to become pregnant, during the course of the study period, or are currently breast feeding mothers. * Females of childbearing potential who are unwilling to use an adequate method of contraception from at least 4 weeks prior to the first application of treatment and until 4 weeks after the last application of treatment, or who are unwilling to take a urine pregnancy test. * Prospective participants who have participated in another clinical study or used an investigational new drug within 1 month before entry into this study. * Participants who have already participated in this clinical study.

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Infestation Successfully Eliminated by Active Treatment.Study Day 22 +/-2Successful elimination of infestation by active treatment \[Time frame: 22 + 2 days\]. No evidence of active head lice infestation 22 days after enrollment.

Countries

United States

Participant flow

Participants by arm

ArmCount
Benzyl Alcohol Lotion 5%
Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out. Benzyl Alcohol Lotion 5%: White topical lotion
107
Ulesfia (Benzyl Alcohol Lotion 5%)
Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out. Ulesfia (benzyl alcohol lotion) 5%: White topical lotion
108
Vehicle Placebo Lotion 0%
Day 1- Sufficient to saturate hair and scalp for 10 min and then washed out. Day 8 -Sufficient to saturate hair and scalp for 10 min and then washed out. Placebo: White topical lotion
24
Total239

Baseline characteristics

CharacteristicBenzyl Alcohol Lotion 5%Ulesfia (Benzyl Alcohol Lotion 5%)Vehicle Placebo Lotion 0%Total
Age, Categorical
<=18 years
77 Participants85 Participants18 Participants180 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
30 Participants23 Participants6 Participants59 Participants
Region of Enrollment
United States
107 participants108 participants24 participants239 participants
Sex: Female, Male
Female
102 Participants98 Participants24 Participants224 Participants
Sex: Female, Male
Male
5 Participants10 Participants0 Participants15 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
deaths
Total, all-cause mortality
0 / 1070 / 1080 / 24
other
Total, other adverse events
2 / 1071 / 1080 / 24
serious
Total, serious adverse events
0 / 1070 / 1080 / 24

Outcome results

Primary

Number of Participants With Infestation Successfully Eliminated by Active Treatment.

Successful elimination of infestation by active treatment \[Time frame: 22 + 2 days\]. No evidence of active head lice infestation 22 days after enrollment.

Time frame: Study Day 22 +/-2

Population: PP

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Benzyl Alcohol Lotion 5%Number of Participants With Infestation Successfully Eliminated by Active Treatment.59 Participants
Ulesfia (Benzyl Alcohol Lotion 5%)Number of Participants With Infestation Successfully Eliminated by Active Treatment.57 Participants
Vehicle Placebo Lotion 0%Number of Participants With Infestation Successfully Eliminated by Active Treatment.6 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026